Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
07/2012
07/18/2012CN102127533B Preparation method of recombinant porcine circovirus type 2 Cap antigen
07/18/2012CN102125620B Traditional Chinese medicinal preparation for treating erysipelas
07/18/2012CN102106857B Compound ceftiofur sodium freeze-dried power injection used for injection
07/18/2012CN102100666B New moxifloxacin hydrochloride injection
07/18/2012CN102060934B Enzymatic extraction method for auricularia auricula polysaccharides
07/18/2012CN102038714B Application of bdellovibrio bdelloplast in preparing bacterial agent for preventing and controlling red mouth disease of scophthalmus maximus
07/18/2012CN102030809B Theasapogenol derivative with antibacterial effect as well as preparation method and application thereof
07/18/2012CN102008436B Nocathiacin antibiotic medicament composition containing emulsifying agent
07/18/2012CN101979581B S7 gene and coded recombinant protein of grass carp reovirus strain, and acquisition method and application thereof
07/18/2012CN101914124B Nucleoside phosphonate conjugates as anti HIV agents
07/18/2012CN101880283B Azaindole kinase inhibitors
07/18/2012CN101879380B Energy-saving concentration process for extracting active ingredients of plants and concentration device thereof
07/18/2012CN101879172B Compound preparation of ceftiofur sodium
07/18/2012CN101863867B Derivatives of flavonoids compounds and preparation method and application thereof
07/18/2012CN101837091B Process for continuously extracting polygonatum saponin and polygonatum polysaccharose
07/18/2012CN101817805B Andrographolide derivative and preparation method and application thereof
07/18/2012CN101810542B Sterilizing bath lotion for furry pets
07/18/2012CN101804112B Preparation method and application of Cyrtomium fortunei and ebony traditional Chinese medicine composite
07/18/2012CN101792743B Recombinant baculovirus expressing porcine circovirus type 2 (PCV-2) immunogen gene and preparation method and application thereof
07/18/2012CN101781293B Antibacterial compound, preparation method and application thereof
07/18/2012CN101736050B Preparation method of arctigenin
07/18/2012CN101735310B Human papilloma virus (HPV) fusion protein, gene, carrier, strain, preparation method and application
07/18/2012CN101730536B Anti-norovirus agent, and composition comprising the same
07/18/2012CN101720326B Novel carbapenem derivatives
07/18/2012CN101715349B Therapeutic compositions and methods for treating gram-negative bacterial infections
07/18/2012CN101693105B Application of IL-4-like recombinant protein of fishes
07/18/2012CN101693051B Preparation method and composition of clerodendranthus spicatus extract
07/18/2012CN101669956B Composition of cefoxitin acid
07/18/2012CN101631790B Compounds for the treatment of hepatitis c
07/18/2012CN101601830B Chinese medicinal preparation for treating cold and preparation method thereof
07/18/2012CN101550153B Fluorine-containing optically active composition for anti-infection
07/18/2012CN101537188B Pinocembrin and cyclodextrin or cyclodextrin derivative inclusion compound
07/18/2012CN101530405B Citric acid and compound citric acid application in pharmacy
07/18/2012CN101503397B Halogenated furan ketone compound, and use thereof in antiinfective drug preparation
07/18/2012CN101501038B Fused [d]pyridazin-7-ones
07/18/2012CN101480391B Application of sophocarpine in preparing medicament for treating disease induced by coxsachie A virus
07/18/2012CN101468099B Chinese medicinal composition for dispersing wind, relieving exterior syndrome, clearing heat and detoxicating, and method for preparing the same
07/18/2012CN101439062B Chinese medicine granule containing andrographolide and preparation method thereof
07/18/2012CN101407476B M-bis(arene) polysubstituted aniline compound as non-nucleoside HIV reverse transcriptase inhibitor, and preparation and use thereof
07/18/2012CN101376870B Chinese herbal medicine wine capable of activating blood circulation, removing stasis, expelling toxin and relieving itching
07/18/2012CN101374845B Novel compounds and use thereof
07/18/2012CN101361765B Anti-coxsackie and anti-herpesvirus extract of selaginella tamariscina and extraction technique and formulation thereof
07/18/2012CN101327249B Use of hydroxyphenyl lactic acid in preparing medicine for treating septicemia
07/18/2012CN101273030B Macrocyclic inhibitors of hepatitis C virus
07/18/2012CN101243104B Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system
07/18/2012CN101189252B Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
07/18/2012CN101167779B Application of Lagotis glauca gaertn extract in preparing antiviral medicine
07/18/2012CN101137391B Uses of recombinant super-compound interferon
07/18/2012CN101137358B Antiviral compositions and methods of use
07/18/2012CN101108872B Plants natural base extract and formulated product and use thereof
07/18/2012CN101019967B Process of preparing antiviral medicine composition
07/17/2012US8222398 Chimeric immunomodulatory compounds and methods of using the same-II
07/17/2012US8221790 Therapeutic polyesters and polyamides
07/17/2012US8221768 Chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence
07/17/2012US8221761 Enhancement of bactericidal activity of neisseria antigens with oligonucleotides containing CG motifs
07/17/2012US8221737 Hepatitis C virus inhibitors
07/17/2012CA2718348C Orally administered peptides to ameliorate atherosclerosis
07/17/2012CA2700319C Carbonates for use in the preparation of derivatives of dioxan-2-alkyl carbamates
07/17/2012CA2659917C Encapsulated vaccines for the oral vaccination and boostering of fish and other animals
07/17/2012CA2535313C Hiv replication inhibiting purine derivatives
07/17/2012CA2522561C Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors
07/17/2012CA2492659C 6-(3-pyridyl-methylamino)purine derivatives and their use as antiproliferative agents
07/17/2012CA2488366C Biofunctional cpg or oligo-/polynucleotide and toxin or enterotoxin containing composition
07/17/2012CA2487968C A novel drug dosing regimen
07/17/2012CA2482002C Curcumin analogues and uses thereof
07/17/2012CA2462455C Development of a preventive vaccine for filovirus infection in primates
07/17/2012CA2446955C A device for forming or increasing the number of undifferentiated cells
07/17/2012CA2418984C Method for obtaining cocoa bean polyphenol extracts, resulting extracts and uses thereof
07/17/2012CA2391392C Methods for screening candidate drugs that disrupt mif and jab1 interaction, mif and jab1 complex, antibodies and uses thereof
07/17/2012CA2277486C Synthetic antibiotics
07/12/2012WO2012094360A2 Biotherapeutics for the treatment of infectious diseases
07/12/2012WO2012093859A2 Antifungal composition including polycyclic peptide compound and method for producing same
07/12/2012WO2012093855A2 Novel flavi mycin compound, antifungal composition including same, and method for producing same
07/12/2012WO2012093681A1 Method for selecting patient to be given drug for treating septicemia
07/12/2012WO2012093647A1 Solution for treatment of bacterial disease in animals and plants by reishi kazuno extract and production method therefor
07/12/2012WO2012093293A1 Process for preparation of caspofungin acetate and intermediates
07/12/2012WO2012093234A2 Sulphated arabinogalactans, apiogalacturonans and sulphated heteroglycans for treating diseases caused by the influenza virus
07/12/2012WO2012093227A1 Prodrugs for dispensing a statin to the liver
07/12/2012WO2012093192A1 Coly-mycin derivatives
07/12/2012WO2012093137A1 Liposome formulation suitable for treating or preventing tuberculosis
07/12/2012WO2012092880A1 2,4-DIAMINO-6,7-DIHYDRO-5H-PYRROLO[2,3]PYRIMIDINE DERIVATIVES AS FAK/Pyk2 INHIBITORS
07/12/2012WO2012092664A1 Monoclonal anti-anti-mhc antibodies and uses thereof
07/12/2012WO2012065055A3 Fusion proteins for hiv therapy
07/12/2012WO2012061822A9 Materials and methods for mobilizing cells including cd34+, hematopoietic colony forming, and endothelial colony forming cells
07/12/2012WO2011116245A3 Methods of treating inflammation
07/12/2012US20120178915 Pyrimidine derivatives and analogs, preparation method and use thereof
07/12/2012US20120178820 Method for treating arthritis
07/12/2012US20120178811 Method of using beta-hydroxy-beta-methylbutyrate to reduce the risk of infection in an elderly individual
07/12/2012US20120178802 2,3-Fluorinated Glycosides as Neuraminidase Inhibitors and Their Use as Anti-Virals
07/12/2012US20120178793 Nucleotide-cochleate compositions and methods of use
07/12/2012US20120178791 MODULATION OF HUMAN CYTOMEGALOVIRUS REPLICATION BY MICRO-RNA 132 (miR132), MICRO-RNA 145 (miR145) AND MICRO-RNA 212 (miR212)
07/12/2012US20120178781 Kappa opioid receptor ligands
07/12/2012US20120178767 Treatment of liver disorders with p13k inhibitors
07/12/2012US20120178759 Condensed pyridine derivatives useful as potent inhibitors of the protein kinase ck2
07/12/2012US20120178749 Ns1 protein inhibitors
07/12/2012US20120178743 Novel adenine compound and use thereof
07/12/2012US20120178731 Nasal, wound and skin formulations and methods for control of antibiotic-resistant staphylococci and other gram-positive bacteria
07/12/2012US20120178727 Combination and composition that contains an antimicrobial, a glucocorticoid and an antimycotic
07/12/2012US20120178717 4-quinolinemethanols as anti-malarial agents
07/12/2012US20120178714 Phosphorus-containing Compounds & Uses Thereof
1 ... 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 ... 1798